| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/23/2000 | US6066498 Compositions for the treatment and diagnosis of immune disorders |
| 05/23/2000 | US6066475 Parathyroid cytosolic autoantigens recognized by autoantibodies from patients with acquired hypoparathyroidism |
| 05/23/2000 | US6066465 Measuring concentration of cyclophilins in blood sample, comparing to control, and evaluating degree of shock by increase of cytophilin concentration over control levels |
| 05/23/2000 | US6066340 Process for the preparation of microspheres containing biologically active components |
| 05/23/2000 | US6066324 Carboxyl terminal of papilloma virus L1 region is not required for formation of virus-like particles |
| 05/23/2000 | US6066323 Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents |
| 05/23/2000 | US6066322 Administering antibody to treat asthma; treating helper t-cell mediated conditions |
| 05/23/2000 | US6066320 Isolating antiserum with nerve cells presenting anti-prion protein |
| 05/23/2000 | CA2290197A1 Vaccine against swine influenza virus |
| 05/23/2000 | CA2072125C Design and construction of non-infectious human retroviral mutants deficient in genomic rna |
| 05/23/2000 | CA2066998C Recombinant varicella-zoster virus and process for constructing same |
| 05/18/2000 | WO2000028040A2 Cloning of rhadinovirus genome and methods for its use |
| 05/18/2000 | WO2000028039A2 Identification of senv genotypes |
| 05/18/2000 | WO2000028038A2 Virulence genes and proteins, and their use |
| 05/18/2000 | WO2000028037A1 CATFIIIA CANDIDA ALBICANS tfIIIA GENE (CatfIIIA) AND THE CODED CATFIIIA PROTEIN |
| 05/18/2000 | WO2000028029A2 Cell surface glycoproteins |
| 05/18/2000 | WO2000028027A2 Corticosteroid synthesis-associated genes |
| 05/18/2000 | WO2000028020A2 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor |
| 05/18/2000 | WO2000028016A1 T cells specific for target antigens and methods and vaccines based thereon |
| 05/18/2000 | WO2000028009A1 Biological compositions, components thereof and uses therefor |
| 05/18/2000 | WO2000028004A1 Virus vectors and methods of making and administering the same |
| 05/18/2000 | WO2000028003A1 Avipox vector coding an hiv antigen and a cytokine |
| 05/18/2000 | WO2000028001A1 Modified exosomes and uses |
| 05/18/2000 | WO2000027994A2 Chlamydia pneumoniae genome sequence |
| 05/18/2000 | WO2000027880A2 Rantes-derived peptides with anti-hiv activity |
| 05/18/2000 | WO2000027879A1 Platelet-derived growth factor d, dna coding therefor, and uses thereof |
| 05/18/2000 | WO2000027877A1 Novel major facilitator superfamily polypeptide, uses thereof and nucleic acids encoding same |
| 05/18/2000 | WO2000027874A2 Nucleic acids encoding transferrin receptor-like proteins and products related thereto |
| 05/18/2000 | WO2000027870A1 Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 05/18/2000 | WO2000027864A1 CHROMOSOME 17p-LINKED PROSTATE CANCER SUSCEPTIBILITY GENE |
| 05/18/2000 | WO2000027433A1 Chimeric anti-cd20 antibody treatment of patients receiving bmt or pbsc transplants |
| 05/18/2000 | WO2000027432A1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS |
| 05/18/2000 | WO2000027431A1 Method of treating arthritis with human parvovirus b19 antigens or antibodies against same |
| 05/18/2000 | WO2000027430A2 Composition consisting of influenza virus surface proteins and dispensing device |
| 05/18/2000 | WO2000027429A2 Vaccine against papillomatous digital dermatitis (pdd) |
| 05/18/2000 | WO2000027428A1 Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-cd20 antibody |
| 05/18/2000 | WO2000027427A1 trmD |
| 05/18/2000 | WO2000027426A1 Method for enhancing proliferation of inner ear hair cells using ligands for her2 and/or her3 receptors |
| 05/18/2000 | WO2000027414A2 Inhibition of the formation of vascular hyperpermeability |
| 05/18/2000 | WO2000027410A2 Composition and method for increasing weight gain and feed efficiency |
| 05/18/2000 | WO2000027205A1 A recombinant polypeptide for use in the manufacture of vaccines against campylobacter induced diarrhea and to reduce colonization |
| 05/18/2000 | WO2000009699A3 Method for producing yeast expressed hpv types 6 and 16 capsid proteins |
| 05/18/2000 | WO2000009560A3 Generation of modified molecules with increased serum half-lives |
| 05/18/2000 | WO2000008181A3 Chp polypeptide, a ligand of pak65 |
| 05/18/2000 | DE19850718C1 Zellpermeabilität-vermittelndes Polypeptid Cell permeability-mediating polypeptide |
| 05/18/2000 | CA2351145A1 Vaccine against papillomatous digital dermatitis (pdd) |
| 05/18/2000 | CA2351017A1 Catfiiia candida albicans tfiiia gene (catfiiia) and the coded catfiiia protein |
| 05/18/2000 | CA2350775A1 Chlamydia pneumoniae genome sequence |
| 05/18/2000 | CA2350183A1 Use of an enterobacterium protein ompa for specific targeting towards antigen-presenting cells |
| 05/18/2000 | CA2350087A1 Chromosome 17p-linked prostate cancer susceptibility gene |
| 05/18/2000 | CA2350086A1 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor |
| 05/18/2000 | CA2350058A1 Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-cd20 antibody |
| 05/18/2000 | CA2349951A1 Platelet-derived growth factor d, dna coding therefor, and uses thereof |
| 05/18/2000 | CA2349761A1 Corticosteroid synthesis-associated genes |
| 05/18/2000 | CA2349679A1 Modified exosomes and uses |
| 05/18/2000 | CA2349449A1 Cell surface glycoproteins |
| 05/18/2000 | CA2348727A1 Composition and method for increasing weight gain and feed efficiency |
| 05/18/2000 | CA2348699A1 Virulence genes and proteins, and their use |
| 05/18/2000 | CA2348382A1 Chimeric parvovirus vectors and methods of making and administering the same |
| 05/18/2000 | CA2348308A1 Rantes-derived peptides with anti-hiv activity |
| 05/18/2000 | CA2347916A1 Inhibition of the formation of vascular hyperpermeability |
| 05/17/2000 | EP1001032A2 Recombinant retroviruses delivering vector constructs to target cells |
| 05/17/2000 | EP1001030A1 Recombinant CELO virus and CELO virus DNA |
| 05/17/2000 | EP1001025A2 Outer membrane proteins from actinobacillus pleuropneumoniae |
| 05/17/2000 | EP1001023A2 Frizzled-4, a putative Wnt-receptor |
| 05/17/2000 | EP1001022A1 CAMEL, an alternative translation product of the tumour antigen LAGE-1 |
| 05/17/2000 | EP1000628A1 Use of antigenic complexes of HIV envelope and HLA class I antigens as HIV vaccine |
| 05/17/2000 | EP1000357A1 Antibodies and scfv immunotoxins specific to imported fire ants, and their application |
| 05/17/2000 | EP1000168A2 A swine hepatitis e virus and uses thereof |
| 05/17/2000 | EP1000163A1 $i(PSEUDOMONAS) EXOTOXIN A-LIKE CHIMERIC IMMUNOGENS |
| 05/17/2000 | EP1000162A1 $i(PSEUDOMONAS) EXOTOXIN A-LIKE CHIMERIC IMMUNOGENS FOR ELICITING A SECRETORY IGA-MEDIATED IMMUNE RESPONSE |
| 05/17/2000 | EP1000158A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 05/17/2000 | EP1000157A1 Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy |
| 05/17/2000 | EP1000144A2 Lactoferrin receptor genes of moraxella |
| 05/17/2000 | EP1000087A2 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same |
| 05/17/2000 | EP1000082A2 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/17/2000 | EP1000076A1 HEXADECASACCHARIDE-PROTEIN CONJUGATE VACCINE FOR $i(SHIGELLA DYSENTERIAE) TYPE 1 |
| 05/17/2000 | EP0999853A1 Stabilized antibody formulation |
| 05/17/2000 | EP0999852A1 Oil in water vaccine compositions |
| 05/17/2000 | EP0703922B1 Method for producing immunoglobulin g concentrate |
| 05/17/2000 | EP0574461B1 High affinity humanized monoclonal antibodies |
| 05/17/2000 | CN1253589A Human complement C3-degrading proteinase from streptococcus pneumoniae |
| 05/17/2000 | CN1253567A Cell surface molecule mediating cell adhesion and signal transmission |
| 05/17/2000 | CN1253506A Chimeric flavirirus vaccines |
| 05/17/2000 | CN1253176A Composition and method for protecting animals from diseases related with slow action virus |
| 05/17/2000 | CN1052510C Mammalian receptors for interleukin-10 |
| 05/16/2000 | US6063906 Antibodies to integrin alpha subunit |
| 05/16/2000 | US6063904 Isolated envelope protein with an amino acid sequence deletion; for efficient recombinant expression; for vaccines; for diagnostic reagents |
| 05/16/2000 | US6063900 Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof |
| 05/16/2000 | US6063770 Tannic acid compositions for treating cancer |
| 05/16/2000 | US6063766 Drugs and proteins from blood with amino acid sequences |
| 05/16/2000 | US6063760 Proteins with amino acid sequences |
| 05/16/2000 | US6063628 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA |
| 05/16/2000 | US6063623 Transport protein which effects the transport of cationic xenobiotics and/or pharmaceuticals, DNA sequences encoding it and their use |
| 05/16/2000 | US6063620 Type I angiotensin II receptor specific monoclonal antibodies and hybridomas |
| 05/16/2000 | US6063610 Flea hydrolase enzyme; for development of antibodies to prevent parasitic infection of plant and animals |
| 05/16/2000 | US6063609 Expression vector comprising an enzymatic protein; for use as diagnostic tools as well as antiarthritic, antiproliferative, anticarcinogenic, antitumor and antiinflammatory agents |
| 05/16/2000 | US6063599 Nucleic acid sequence of parasite polypeptide; for diagnosis of parasitic helminth infection; for the development of vaccines to prevent helminth and nematode infection |
| 05/16/2000 | US6063563 Method of PCR testing of pooled blood samples |
| 05/16/2000 | US6063386 Recombinant multivalent M protein vaccine |